# Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone

> **NCT06321666** · NA · UNKNOWN · sponsor: **European Institute of Oncology** · enrollment: 58 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **OTHER:** WB-MRI

## Key facts

- **NCT ID:** NCT06321666
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-12
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06321666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06321666, "Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone". Retrieved via MORVS 2026-10-14 from https://api.morvs.ai/clinical/NCT06321666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*